{"name":"New Haven Pharmaceuticals","permalink":"new-haven-pharmaceuticals","crunchbase_url":"http://www.crunchbase.com/company/new-haven-pharmaceuticals","homepage_url":"http://www.newhavenpharma.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"NHP","email_address":"","phone_number":"770-329-0074","description":"","created_at":"Tue Oct 30 02:07:21 UTC 2012","updated_at":"Tue Oct 30 02:13:33 UTC 2012","overview":"<p>New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications that represent significant market opportunities. The company&#8217;s novel product pipeline employs proprietary, oral, controlled-release technologies, as well as intellectual property licensed from Yale University, which will enable optimal dosing, safety, efficacy and patient convenience.</p>","image":{"available_sizes":[[[150,39],"assets/images/resized/0021/7827/217827v1-max-150x150.jpg"],[[250,66],"assets/images/resized/0021/7827/217827v1-max-250x250.jpg"],[[450,119],"assets/images/resized/0021/7827/217827v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$6M","funding_rounds":[{"round_code":"a","source_url":"http://www.masshightech.com/stories/2012/10/29/daily6-New-Haven-Pharma-gets-6M-prepares-for-approval.html","source_description":"New Haven Pharma gets $6M, prepares for approval","raised_amount":6000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":29,"investments":[{"company":null,"financial_org":{"name":"Connecticut Innovations","permalink":"connecticut-innovations","image":{"available_sizes":[[[145,83],"assets/images/resized/0002/3444/23444v1-max-150x150.jpg"],[[145,83],"assets/images/resized/0002/3444/23444v1-max-250x250.jpg"],[[145,83],"assets/images/resized/0002/3444/23444v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"EJ Funds","permalink":"ej-funds","image":null},"person":null},{"company":null,"financial_org":{"name":"Kuzari Group","permalink":"kuzari-group","image":null},"person":null},{"company":null,"financial_org":{"name":"Advantage Capital Partners","permalink":"advantage-capital-partners","image":{"available_sizes":[[[150,105],"assets/images/resized/0002/1156/21156v1-max-150x150.jpg"],[[176,124],"assets/images/resized/0002/1156/21156v1-max-250x250.jpg"],[[176,124],"assets/images/resized/0002/1156/21156v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"P.O. Box 586","address2":"","zip_code":"06437","city":"Guilford","state_code":"CT","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}